For instance, elevated expression of angiogenic factors such as basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and transforming growth factor-β1 (TGF-β1) in cerebrospinal fluid, plasma or serum was observed in MMD patients[18–21]. This evidence concerns the gene TGFB1 and multiminicore myopathy.